Successful treatment of hidradenitis suppurativa with rituximab for a patient with idiopathic carpotarsal osteolysis and chronic active antibody-mediated rejection

J Dermatol. 2018 May;45(5):e116-e117. doi: 10.1111/1346-8138.14144. Epub 2017 Nov 23.

Authors

Affiliations

¹ Departments of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
² Department of Urology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

PMID: 29168221
DOI: 10.1111/1346-8138.14144

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies / immunology
Axilla
Chronic Disease
Graft Rejection / drug therapy
Graft Rejection / immunology*
Groin
Hidradenitis Suppurativa / diagnosis
Hidradenitis Suppurativa / drug therapy*
Hidradenitis Suppurativa / etiology
Humans
Immunologic Factors / therapeutic use*
Kidney Transplantation / adverse effects
Male
Osteolysis / complications*
Renal Insufficiency / etiology
Renal Insufficiency / surgery
Rituximab / therapeutic use*
Treatment Outcome
Young Adult

Substances

Antibodies
Immunologic Factors
Rituximab